HOME
Hepatitis B
Hepatitis C
HIV and AIDS
HIV-HCV Coinfection
HIV-HBV Coinfection
Hepatitis C Main Section
FDA-approved Treatments
Experimental Treatments
HCV Articles by Topic

HCV - Liver Transplantation

Selected Hepatitis C Patients with Decompensated Cirrhosis Can Benefit from Interferon-based Therapy prior to Liver Transplantation - 6/10/08

Marijuana Use Sparks Liver Transplant Controversy - 6/06/08

FibroScan Liver Stiffness Measurement Distinguishes Fast and Slow Fibrosis Patterns after Liver Transplantation - 5/16/08

Prophylaxis with Pegylated Interferon Alfa-2a (Pegasys) plus Ribavirin vs No Prophylaxis after Liver Transplantation - 11/27/07

Sodium Levels Can Help Predict Outcomes before and after Liver Transplantation   - 8/07/07

Treatment of Recurrent Hepatitis C in Liver Transplant Recipients     - 7/10/07

Response to PegIntron/ribavirin Leads to Stabilization of Fibrosis in Liver Transplant Recipients  - 5/01/07

Pegylated Interferon/ribavirin Therapy Results in Low SVR Rates after Liver Transplantation in HIV-HCV Coinfected Patients  - 3/27/07

Sustained Virological Response Improves Fibrosis Progression and Reduces Mortality after Liver Transplantation   2/23/07



 

 

 

 

 


FDA-approved Combination Therapies for Chronic HCV Infection

Pegasys + Copegus
PEG-Intron + Rebetol
Intron A + Rebetol
Roferon A + Ribavirin

Treatment Guidelines